0.12Open0.17Pre Close90 Volume1.25K Open Interest2.50Strike Price920.00Turnover195.58%IV49.43%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.3290Delta0.4051Gamma11.60Leverage Ratio-0.0065Theta0.0003Rho3.82Eff Leverage0.0017Vega
BioAtla Stock Discussion
Bioatla Announces FDA Clearance of Investigational New Drug Application for Ba3361, a Cab-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
NEWS
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
$Arbor Realty Trust Inc(ABR.US)$ $AGBA Group(AGBA.US)$ $BridgeBio Pharma(BBIO.US)$ $BioAtla(BCAB.US)$ $Bakkt Holdings(BKKT.US)$ $Cosmos Health(COSM.US)$ $Futu Holdings Ltd(FUTU.US)$ $Iovance Biotherapeutics(IOVA.US)$ $Lululemon Athletica(LULU.US)$ $MGM Resorts International(MGM.US)$ $NuCana(NCNA.US)$ $NextEra Energy(NEE.US)$ $Dave & Buster's Entertainment(PLAY.US)$ $Silvergate Capital(SI.US)$ $Virgin Galactic(SPCE.US)$
$AbbVie(ABBV.US)$ $Broadcom(AVGO.US)$ $BioAtla(BCAB.US)$ $Biora Therapeutics(BIOR.US)$ $DermTech(DMTK.US)$ $Broadwind(BWEN.US)$ $CureVac(CVAC.US)$ $EVgo Inc(EVGO.US)$ $Hepion Pharmaceuticals(HEPA.US)$ $AMTD Digital(HKD.US)$ $Ichor Holdings(ICHR.US)$ $MasterCard(MA.US)$ $NextPlay Technologies(NXTP.US)$ $Party City Holdco(PRTY.US)$ $Starbucks(SBUX.US)$
No comment yet